Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Partial Breast Re-irradiation Using Ultra Hypofractionation: Phase 2 Multi-institutional Study (PRESERVE)

NCT05592938 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT05592938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05592938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Partial Breast Re-irradiation Using Ultra Hypofractionation: Phase 2 Multi-institutional Study (PRESERVE)
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Recruiting
Start date
June 27, 2023
Completion date
June 27, 2027
Enrollment
171 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer recurrent